Acrivon Therapeutics (ACRV) Change in Accured Expenses (2021 - 2026)
Acrivon Therapeutics' Change in Accured Expenses came in at $711,000 for Q2 2026, down 67.0% from $2.15 million a year earlier.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Acrivon Therapeutics reported Change in Accured Expenses of -$1.18 million; for FY2025, it was -$3.35 million.
- Going back by year, Change in Accured Expenses was $8.02 million in FY2024 (+152.8%), $3.17 million in FY2023 (+8.7%), $2.92 million in FY2022 (+237.1%) and $866,000 in FY2021.
- The five-year range for quarterly Change in Accured Expenses is -$7 million (Q1 2025) to $3.46 million (Q3 2024).
- Year-over-year, Change in Accured Expenses increased in two of the last five quarters, with growth averaging 28.4%.
- The fastest year-over-year change in Change in Accured Expenses over five years came in Q4 2024 (growth of 205.8%), and the weakest in Q2 2026 (a decline of 67.0%).
- Business Quant data shows ACRV's Change in Accured Expenses at -$3.38 million (Q1 2026), -$481,000 (Q4 2025) and $1.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - | 711,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 711,000.00 |
| Mar 31, 2026 | -3.38 Mn |
| Dec 31, 2025 | -481,000.00 |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 2.15 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | -1.48 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | -1.32 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 978,000.00 |
| Jun 30, 2022 | 736,000.00 |
| Mar 31, 2022 | -326,000.00 |
| Dec 31, 2021 | 1.00 Mn |
API Access
Acrivon Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();